source
- Novo and Anthropic partner to test Claude Science AI platform in drug discovery R&DNovo, the Danish pharmaceutical company, announced a partnership with AI firm Anthropic. The collaboration will focus on evaluating Anthropic’s Claude Science AI model within Novo’s research and d…
- Novartis scraps TREM2 ALS candidate after Phase 2 failureNovartis announced it is halting development of its TREM2-targeting drug VHB937, also known as lifonebart, after the Phase 2 trial in amyotrophic lateral sclerosis (ALS) did not meet its primary en…